Joseph Hernandez

CIK 1598384 · Chief Executive Officer · last filed 2026-03-24

Joseph Hernandez is a Chief Executive Officer who has filed 12 SEC Form 4 insider transactions across 6 companies since 2020. The most recent filing, for BWIV.U, was dated Mar 24, 2026. Across all open-market trades the lifetime net is −$7.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $10.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$10.00M

Companies

6

Total Filings

12

Lifetime Open-Market Net

-$7.81M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BWIV.U Chief Executive Officer 275,000 $10.05 $2.76M $0 1 2026-03-24
BLUWW Chief Executive Officer 430,000 $0.42 $180.3K $0 1 2025-11-28
BLUWU Chief Executive Officer 430,000 $10.60 $4.56M $0 1 2025-06-12
Onconetix, Inc. (BWV) Delisted CEO 2,800,351 $0.18 $504.6K -$2.64M 3 2023-05-11
Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted Director 1,308,266 $0.01 $17.8K $0 3 2022-06-09
OGEN 10%+ Owner 4,023,997 $0.62 $2.49M -$5.17M 2 2021-01-26

Recent Filings

12 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-03-24 BWIV.U Buy (P) +275,000 $0 EDGAR
2025-11-28 BLUWW Mixed −430,000 $0 EDGAR
2025-06-12 BLUWU Buy (P) +430,000 $0 EDGAR
2023-05-11 Onconetix, Inc. (BWV) Delisted Grant (A) +150,000 $0 EDGAR
2022-08-22 Onconetix, Inc. (BWV) Delisted Sell (S) −549,649 -$2.64M EDGAR
2022-06-09 Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted Grant (A) +1,922 $0 EDGAR
2022-05-27 Onconetix, Inc. (BWV) Delisted Grant (A) $0 EDGAR
2022-04-27 Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted Mixed +1,172,500 $0 EDGAR
2021-12-14 Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted Grant (A) +3,844 $0 EDGAR
2021-09-13 Mixed +2,605,000 $0
Showing 110 of 12
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.